[Choice of drugs--by whom, for whom and to what costs?].
作者信息
Frisk M, Strömstedt A
机构信息
Klinisk farmakologi, Uppsala universitet.
出版信息
Lakartidningen. 2000 Sep 27;97(39):4343-6.
PMID:11076479
Abstract
摘要
相似文献
1
[Choice of drugs--by whom, for whom and to what costs?].
Lakartidningen. 2000 Sep 27;97(39):4343-6.
2
[Drug committees should be abolished because the reality has changed].
Lakartidningen. 2005;102(11):880-1; discussion 882-3.
3
[Reply 1: LAKSAK supports wise drug therapy using knowledge and sharp IT-tools].回复1：LAKSAK利用知识和先进的信息技术工具支持明智的药物治疗。
Lakartidningen. 2000 Sep 27;97(39):4347.
4
[Feedback on prescribing profiles at a primary health center. Important element in quality assurance of drug prescription].[基层医疗中心处方概况反馈。药物处方质量保证的重要因素]
Lakartidningen. 2001 Jan 17;98(3):160-4.
5
[Treatment of the non-hospitalised patient and the consumption of drugs].[非住院患者的治疗与药物消费]
Lakartidningen. 1980 Mar 12;77(11):1002-4.
6
[Drug committees in Denmark. Status and future challenges].
Ugeskr Laeger. 2004 Aug 23;166(35):2988-91.
7
[Medical experts groups and choice of medications. A fair prioritization process guarantees the reliability of the choice of medications].[医学专家组与药物选择。公平的优先排序过程可确保药物选择的可靠性]
Lakartidningen. 2004 Aug 5;101(32-33):2480-2, 2484.
8
[Health economics evaluations are of great significance for Pharmaceutical Benefit Board's decisions].卫生经济学评估对药品福利委员会的决策具有重要意义。
Lakartidningen. 2007;104(42):3046-50.
9
[The discussion on the choice of drugs requires more facts].关于药物选择的讨论需要更多事实。
Lakartidningen. 1999 Sep 22;96(38):4011.
10
[Cost savings by right choice of drugs. Decision making models for "good prescription" are presented].[通过正确选择药物节省成本。介绍了“合理处方”的决策模型]
Lakartidningen. 1997 Feb 26;94(9):733-6, 739.
Zotero 插件